摘要:
A call control method, a communication system, and relevant devices are provided so that communications can be implemented under different network conditions based on the same number. The method includes: receiving a call request of a calling terminal, where the call request carries a called terminal number; querying a Home Location Register (HLR) of a called terminal according to the called terminal number; obtaining a Supplementary Service Code (SS_Code) from the HLR, where the SS_Code carries a Mobile Station International ISDN Number (MSISDN)-based IP Multimedia Subsystem (IMS) service identifier; and triggering an Application Server (AS) to implement an MSISDN-based IMS service according to the MSISDN-based IMS service identifier. A communication system and relevant devices are also provided.
摘要:
A call control method, a communication system, and relevant devices are provided so that communications can be implemented under different network conditions based on the same number. The method includes: receiving a call request of a calling terminal, where the call request carries a called terminal number; querying a Home Location Register (HLR) of a called terminal according to the called terminal number; obtaining a Supplementary Service Code (SS_Code) from the HLR, where the SS_Code carries a Mobile Station International ISDN Number (MSISDN)-based IP Multimedia Subsystem (IMS) service identifier; and triggering an Application Server (AS) to implement an MSISDN-based IMS service according to the MSISDN-based IMS service identifier. A communication system and relevant devices are also provided.
摘要:
A method for switching call between a mobile terminal with the same number and a soft terminal includes: receiving the switching instruction information sent by the soft terminal user during the call between the soft terminal or the mobile terminal with the same number and the opposing user; confirming the type of the switching instruction information, and carrying out the switching performance between the mobile terminal with the same number and the soft terminal according to the type of the switching instruction information. A system and an equipment for switching call between a mobile terminal with the same number and a PC client are disclosed in the present invention.
摘要:
Liquid formulations of celecoxib have been found to provide faster pain relief than conventional solid formulations of celecoxib. The present invention provides combinations of excipients in which celecoxib is highly soluble for formulation as pharmaceutical compositions.
摘要:
The invention provides novel liquid lansoprazole formulations comprising lansoprazole and an excipient system, wherein: (a) the concentration of lansoprazole in the formulations ranges from about 0.3 mg/mL to about 50 mg/mL; (b) the excipient system comprises either a single excipient, or a combination of two to four compositionally distinct excipients; and (c) the formulations may be administered parenterally to a mammal to treat or prevent a gastrointestinal disorder.
摘要:
The present invention provides aqueous pharmaceutical compositions containing a lipophilic therapeutic agent. In particular, the invention provides aqueous pharmaceutical compositions containing the compound 2,6-diisopropylphenol (propofol). Preferred compositions of the invention contain propofol in the presence of at least one block copolymer (for example, P188 or another poloxamer) and a polyethylene glycol (PEG). Compositions of the invention are preferably sterile or are readily sterilized (e.g., by autoclaving) and are suitable for parenteral administration to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions and for extended periods of time.
摘要:
The present invention provides aqueous pharmaceutical compositions containing a lipophilic therapeutic agent. In particular, the invention provides aqueous pharmaceutical compositions containing the compound 2,6-diisopropylphenol (propofol). Preferred compositions of the invention contain propofol in the presence of at least one block copolymer (for example, P188 or another poloxamer) and a polyethylene glycol (PEG). Compositions of the invention are preferably sterile or are readily sterilized (e.g., by autoclaving) and are suitable for parenteral administration to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions and for extended periods of time.
摘要:
The invention concerns paclitaxel solubilizers and formulations thereof with a high propensity to dissolve paclitaxel. The formulations of the invention reduce or obviate the need for the disadvantageous excipient Cremophor® EL. The formulations of the invention are useful for administering paclitaxel, its derivatives, or pharmaceutically acceptable salts or such derivatives to patients in need thereof. The formulations of the invention are suitable for parenteral, oral, local, or transdermal administration to mammals including humans, particularly for intravenous delivery.
摘要:
The invention relates to methods of screening mixtures containing a pharmaceutical compound and an excipient to identify properties of the pharmaceutical compound/excipient combination that retard solid-state nucleation. The invention further relates to increasing the solubility, dissolution and bioavailability of a drug with low solubility in gastric fluids conditions by combining the drug with a recrystallization/precipitation retardant and an optional enhancer.